Efficacy of Novel Multimodality Pigment-Correcting Serum for Moderate to Severe Facial Hyperpigmentation, Including Melasma, in a 12-Week, Split-Face, Double-blind, Randomized Controlled Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s190, 2023. DOI: 10.25251/skin.7.supp.190. Disponível em: https://skin.dermsquared.com/skin/article/view/1992. Acesso em: 25 nov. 2025.